Definition

A preparation of natural killer cells (NKs) expressing a chimeric antigen receptor (CAR) specific for an as of yet undisclosed tumor-associated antigen (TAA), with potential immunomodulating and antineoplastic activities. Upon administration, the CAR-NK cells SZ011 recognize and induce selective cytotoxicity in tumor cells expressing the TAA.